• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝细胞癌切除术。153例多中心系列病例的预后因素分析]

[Resection of hepatocellular carcinomas. Analysis of prognostic factors of a multicenter series of 153 patients].

作者信息

Pitre J, Houssin D, Kracht M

机构信息

Clinique Chirurgicale Hôpital Cochin, Paris.

出版信息

Gastroenterol Clin Biol. 1993;17(3):200-6.

PMID:8392476
Abstract

In order to identify the prognostic factors of the resection of hepatocellular carcinoma, the results of 153 resections performed between January 1984 and December 1988 in 18 French centers were analysed. Cirrhosis was present in 76% of the patients. Among the postoperative complications (61%), the most frequent were ascites (35.3%) and liver failure (19%). Operative mortality was 20%. One-, 3- and 5-year survival rates were 52.7, 30.1, and 17.9%, respectively. The survival rate was significantly higher in patients with a curative resection, Pugh's class A or with a tumor less than 3 centimeters in diameter. After curative resection, actuarial survival rates without recurrence were 65, 24.4, and 16.7% after, 1, 3, and 4 years respectively. In this case, the survival rate was significantly related to the number of resected nodules and the size of the tumor but not to the presence of a capsule surrounding the tumor.

摘要

为了确定肝细胞癌切除术的预后因素,对1984年1月至1988年12月间法国18个中心进行的153例切除术的结果进行了分析。76%的患者存在肝硬化。在术后并发症(61%)中,最常见的是腹水(35.3%)和肝衰竭(19%)。手术死亡率为20%。1年、3年和5年生存率分别为52.7%、30.1%和17.9%。根治性切除、普格分级为A类或肿瘤直径小于3厘米的患者生存率明显更高。根治性切除后,1年、3年和4年后无复发的精算生存率分别为65%、24.4%和16.7%。在这种情况下,生存率与切除结节的数量和肿瘤大小显著相关,但与肿瘤周围包膜的存在无关。

相似文献

1
[Resection of hepatocellular carcinomas. Analysis of prognostic factors of a multicenter series of 153 patients].[肝细胞癌切除术。153例多中心系列病例的预后因素分析]
Gastroenterol Clin Biol. 1993;17(3):200-6.
2
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
3
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].[肝细胞癌肝切除术——当前文献的结果与分析]
Zentralbl Chir. 2009 Apr;134(2):127-35. doi: 10.1055/s-0028-1098881. Epub 2009 Apr 20.
4
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.伴有肝硬化作为孤立性肝细胞癌切除术后复发的一个危险因素。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.
5
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.肝细胞癌肝切除术后的长期预后:204例连续患者的生存分析
Cancer. 1998 Dec 1;83(11):2302-11.
6
[Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].[肝硬化患者肝细胞癌的肝切除与肝移植]
Gastroenterol Clin Biol. 1997;21(8-9):590-5.
7
Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma.影响肝细胞癌肝切除术后肝硬化患者生存及长期预后的因素。
Eur J Surg Oncol. 2000 Jun;26(4):387-92. doi: 10.1053/ejso.1999.0904.
8
[Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].[影响≤3cm小肝细胞癌患者术后生存的预后因素]
Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):579-83.
9
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.共存肝硬化对符合米兰标准的肝细胞癌患者肝部分切除术后结局的影响:293例患者分析
Surgery. 2007 Nov;142(5):685-94. doi: 10.1016/j.surg.2007.05.009.
10
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.直径大于或等于10厘米的肝细胞癌的肝切除术
Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.

引用本文的文献

1
Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation.治疗小尺寸肝癌的可比较及互补性方式:手术切除、射频消融和微波消融
J Clin Med. 2023 Jul 29;12(15):5006. doi: 10.3390/jcm12155006.